Tetra Bio-Pharma & Avicanna Enter Into Strategic Partnership


Tetra Bio-Pharma Inc. TBP TBPMF JAM announced that it has executed a non-binding term sheet with Avicanna Inc. AVCN AVCNF 0NN to assess entering into a strategic partnership comprising of three strategic pillars, including:

  • The registration and commercialization of Tetra's various prescription products (REDUVO, AdVersa, QIXLEEF and CAUMZ) across Avicanna's channels in Latin/South America. This opens the door for Tetra to initiate sales earlier than planned.
  • Supply of Avicanna's Active Pharmaceutical Ingredients (APIs) for Tetra's pharmaceutical pipeline. The phyto-cannabinoid APIs would be sourced from Avicanna's low cost and sustainable operations in Colombia.
  • Co-development and support for Avicanna's pharmaceutical pipeline for Health Canada and FDA level clinical development and registration.

Management Commentary

"Tetra will need multiple reliable suppliers of API, like Avicanna, to support QIXLEEF operations leading to its successful marketing authorization and global sales and distribution,” Steeve Neron, chief commercial officer at Tetra, said. “QIXLEEF is Tetra's proprietary investigational new drug and is currently being evaluation in two U.S. FDA-authorized clinical trials. Additionally, Avicanna's established distribution channels in Latin/South America may help advance Tetra's product commercialization in select jurisdictions".

"We look forward to collaborating with the Tetra team who has in many ways been pioneering cannabinoid- prescription products,” Aras Azadian, CEO of Avicanna, commented on the deal. “As the global industry continues to mature and shift its focus towards evidence-based medicines, the two companies are well positioned to work in synergy across several projects and leverage their leadership positions into fruitful commercial results."

Photo: Courtesy of Cytonn Photography on Unsplash

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsPenny StocksMarketsAras AzadianpartnershipSteeve Neron
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!